Internal Medicine, Pulmonary Disease · Summit, NJ
NPI
1750382818
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1 Springfield Ave, 3rd Floor
Summit, NJ, 07901
Phone (908) 934-0555
Groups this clinician bills Medicare through
Medicare paid, 2024
$204K
2,931 services
Medicare patients, 2024
1,061
Average age 76
Drug cost, 2024
$3.5M
5,607 prescriptions
Company payments, 2025
$1,095
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frederic J Scoopo was code 99214 (office e&m - established), 1,242 times for 721 patients. In total Frederic J Scoopo billed 2,931 services in 27 codes, and Medicare paid $204K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,242 | 721 | $99.37 | $123K |
| 94010 Pulmonary Function Testing | Office | 388 | 359 | $9.05 | $3,510 |
| 99213 Office E&M - Established | Office | 238 | 190 | $70.91 | $17K |
| 94729 Pulmonary Function Testing | Office | 224 | 206 | $12.26 | $2,746 |
| 99215 Office E&M - Established | Office | 111 | 93 | $149.30 | $17K |
| 99233 Hospital E&M - Subsequent | Facility | 104 | 65 | $99.77 | $10K |
| 94726 Pulmonary Function Testing | Office | 86 | 83 | $14.62 | $1,258 |
| 99204 Office E&M - New | Office | 78 | 78 | $124.30 | $9,695 |
| 94060 Pulmonary Function Testing | Office | 71 | 71 | $10.35 | $735 |
| 99232 Hospital E&M - Subsequent | Facility | 58 | 39 | $65.18 | $3,781 |
| 99223 Hospital E&M - Initial | Facility | 52 | 52 | $143.83 | $7,479 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 45 | 40 | $13.98 | $629 |
| 99205 Office E&M - New | Office | 13 | 13 | $166.94 | $2,170 |
By year: 2022 $259K for 3,802 services; 2023 $216K for 3,059 services; 2024 $204K for 2,931 services.
Medicare prescription drug claims, 2024
In 2024, the drug Frederic J Scoopo prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 766 prescriptions and refills. In total Frederic J Scoopo wrote 5,607 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 766 | 1,216 | 156 | $750K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 505 | 710 | 218 | $21K |
| Prednisone Generic | 451 | 688 | 231 | $2,872 |
| Breo Ellipta Fluticasone/Vilanterol | 350 | 554 | 75 | $208K |
| Montelukast Sodium Generic | 271 | 747 | 82 | $4,148 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 216 | 320 | 47 | $143K |
| Azithromycin Generic | 211 | 306 | 77 | $2,058 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 175 | 247 | 42 | $149K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 154 | 240 | 56 | $20K |
| Azelastine Hcl Generic | 149 | 315 | 58 | $5,558 |
| Arnuity Ellipta Fluticasone Furoate | 143 | 241 | 36 | $53K |
| Fluticasone Propionate Generic | 134 | 278 | 56 | $2,895 |
| Spiriva Respimat Tiotropium Bromide | 126 | 203 | 31 | $100K |
| Incruse Ellipta Umeclidinium Bromide | 118 | 146 | 23 | $49K |
| Ventolin Hfa Albuterol Sulfate | 105 | 127 | 44 | $8,112 |
Brand drugs: 3,370 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frederic J Scoopo $1,095 ($1,095 in general payments such as food, travel and fees) from 13 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $410.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 20 | $410 |
| GlaxoSmithKline, LLC. GSK | 22 | $249 |
| Amgen Inc. AMGN | 4 | $83.72 |
| Insmed, Inc. INSM | 4 | $66.89 |
| Genzyme Corporation SNY | 3 | $57.51 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $51.78 |
| Verona Pharma, Inc. VRNA | 2 | $37.18 |
| Grifols USA, LLC | 2 | $32.32 |
| Viatris Specialty LLC | 2 | $29.87 |
| Baxter Healthcare BAX | 1 | $24.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.